Vancouver, BC, April 15, 2024--Achieve Life Sciences, Inc., a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced fourth quarter and year-end 2023 financial results and provided an update on the cytisinicline development program.
|